These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 5134893)

  • 1. Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
    Spark RF; Melby JC
    Ann Intern Med; 1971 Dec; 75(6):831-6. PubMed ID: 5134893
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
    Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone-responsive hypertension in young women with suppressed renin and aldosterone.
    Hoefnagels WH; Drayer JI; Hofman JA; Kloppenborg PW; Smals AG; Benraad TJ
    Lancet; 1978 Apr; 1(8067):741-3. PubMed ID: 76749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
    Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF
    Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088
    [No Abstract]   [Full Text] [Related]  

  • 6. 18-Hydroxy-deoxycorticosterone in human hypertension.
    Melby JC; Dale SL; Wilson TE
    Circ Res; 1971 May; 28(5):Suppl 2:143-52. PubMed ID: 4327960
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.
    Hoffbrand BI; Edmonds CJ; Smith T
    Br Med J; 1976 Mar; 1(6011):682-4. PubMed ID: 766908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of mineralocorticoid hypertension.
    Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
    Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
    Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
    Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.
    Karppanen H; Lahovaara S; Männistö P; Vapaatalo H
    Acta Physiol Scand; 1975 Jun; 94(2):184-8. PubMed ID: 168735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
    Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
    Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
    Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
    Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
    New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
    J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.
    Ferriss JB; Brown JJ; Fraser R; Haywood E; Davies DL; Kay AW; Lever AF; Robertson JI; Owen K; Peart WS
    Br Med J; 1975 Jan; 1(5950):135-8. PubMed ID: 234268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
    Mantero F; Armanini D; Urbani S
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of the mineralocorticoid system in primary hypertension.
    Ferrari P
    Curr Hypertens Rep; 2002 Feb; 4(1):18-24. PubMed ID: 11790287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.